跳至主要内容
临床试验/CTRI/2024/12/078002
CTRI/2024/12/078002尚未招募2 期

RANDOMIZED CONTROLLED CLINICAL TRIAL TO DETERMINE THE EFFECT OF ATIBALA CHURNA (ABUTILON INDICUM) IN THE MANAGEMENT OF RAKTAPRADARA W.S.R ABNORMAL UTERINE BLEEDING

Dr shabanuri wahid khan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To determine the efficacy of Atibala Churna in the management of Raktapradara with special reference to Abnormal Uterine Bleeding.

研究概览

简要总结

Raktapradara is a considerable health care burden for a woman and has a definite effect on her quality of life. It is said presently only hormones, prostaglandin synthesis inhibitors (PSI) and antifibrinolytic agents are available for this condition; these have their own side effects. AUB leads to loss of productivity and may result in surgical interventions including hysterectomy. Thus, to overcome above raised problems in present dissertion study of Atibala Churna is taken in the management of Raktpradara w.s.r to Abnormal uterine bleeding. Atibala Churna is easily available, cost effective and affordable for patient. This study is A  “RANDOMIZED CONTROLLED CLINICAL TRIAL TO DETERMINE THE EFFECT OF ATIBALA CHURNA (ABUTILON INDICUM) IN THE MANAGEMENT OF RAKTAPRADARA W.S.R. TO ABNORMAL UTERINE BLEEDING”.  In this study Randomly 60 patients having signs and symptoms of Raktapradara will be selected from OPD and IPD of sst  Ayurved Ruganalaya. They will be divided in Group A and Group B accordingly (Group A Trial - Atibala Churna with Madhu, Group B control - Yashtimadhu Churna with Madhu). 30 patients in each group will be studied. study will be conducted in India. Outcome of study will be asses on reducing symptoms of raktapradara like Raja ati pravrutti, deergha kala artava pravruttti, shroni prustha kukshi shoola

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Patients having symptoms of Raktpradara i.e 1.Raja Ati Pravrutti (Excessive menstrual bleeding i.e more than 3 pads/day).
  • 2.Deergha Kala Artava Pravrutti.
  • (Menstrual bleeding that last for more than 7 days).
  • 3.Daha in Adho Vankshana (Burning sensation in groin region).
  • 4.Shroni, Prushtha and Kukshi shoola (Pain during menstruation).
  • Hb percentage above 7 gm %.

排除标准

  • Known patients suffering with uterine & pelvic pathology like Uterine fibroid, Adenomyosis, Polyp, Pelvic inflammatory disease, Post-menopausal bleeding, etc.
  • Known patient with any serious systemic disorder like HTM, DM, TB, Thyroid etc.
  • K/C/O Abortion/ ectopic pregnancy.
  • K/C/O PCOD & Other related disease.
  • Patients with IUCD and on OCP pills.
  • Patient taking Anti-coagulation therapy and having any coagulant defects like Thrombocytopenic Purpura.

结局指标

主要结局

To determine the efficacy of Atibala Churna in the management of Raktapradara with special reference to Abnormal Uterine Bleeding.

时间窗: 90 days

次要结局

  • Hemoglobin percentage will be observed(before treatment & after completion of treatment)

研究者

发起方
Dr shabanuri wahid khan
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr shabanuri wahid khan

Sangam Sevabhavi Trust Ayurved Medical College Sangamner

研究点 (1)

Loading locations...

相似试验